Neonatal jaundice is the yellowish discoloration of the skin, conjunctiva, and the sclera due to elevated serum or plasma bilirubin in the newborn period.
Global Neonatal Jaundice Meter Market: Introduction
Neonatal jaundice is the yellowish discoloration of the skin, conjunctiva, and the sclera due to elevated serum or plasma bilirubin in the newborn period. The neonatal jaundice is a non-invasive method to screen babies for jaundice. The product is convenient, effective, and proven, reducing the need for blood sampling and hence, contributing to developmental care practice. Screening using non-invasive measurement can thus offer a simple and convenient way to avoid later complications.
Read Report Overview - https://www.transparencymarketresearch.com/neonatal-jaundice-meter-market.html
Portable transcutaneous jaundice meters offer a quick and easy method for dynamic and ongoing assessment to identify abnormal bilirubin levels. These meters are suitable for use in all clinical settings such as NICU, SCBU, maternity, post-natal, and in the community.
The simplicity of operation and speed of obtaining readings with the jaundice meter that Delta Medical supply, makes repeated testing to measure efficacy of treatment possible, with minimal impact on the patient. The jaundice meter can facilitate routine screening and accelerate appropriate care and treatment of newborns who are detected with elevated bilirubin levels.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=78770
Key Drivers of Global Neonatal Jaundice Meter Market
Increase in demand for effective diagnosis of neonatal jaundice
According to African Journal of Primary Health Care & Family Medicine, the prevalence of neonatal jaundice was 55.2%, which is in accordance with the literature and guidelines where the prevalence is quoted to be between 50% and 60% for healthy term neonates. Of the babies, 19% qualified for phototherapy and a further 10.4% possibly qualified for phototherapy. Neonatal jaundice is not always harmful and a self-limiting condition; however, very high levels of bilirubin may cause permanent brain damage, a condition called kernicterus. Therefore, it is important to diagnose neonatal jaundice and manage it appropriately.
Technological advancements
According to American Academy of Pediatrics, August 2017, BiliCam is a smartphone-based non-invasive medical device, which utilizes on-device camera to monitor yellow discoloration of the skin due to excess deposition of bilirubin. The images of the newborn are collected in a standardized way, directly on the phone. The color (intensity of yellow discoloration) data in the image is used to estimate the bilirubin level.
Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=78770
North America to account for major share of global neonatal jaundice meter market
North America is projected to account for major share of the global neonatal jaundice meter market during the forecast period. The market in the region is anticipated to expand at a rapid pace in the next few years due to an increase in research & development and various government initiatives for the development of novel ideas. Europe is expected to be the second-largest market during the forecast period.
The neonatal jaundice meter market in Asia Pacific is likely to expand at a high CAGR during the forecast period. This can be attributed to a rise in investment in research & development by private & government organizations and increase in healthcare management in the region.
Pre Book Neonatal Jaundice Meter Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=78770<ype=S
Key Players Operating in Global Neonatal Jaundice Meter Market
The global neonatal jaundice meter market is highly consolidated owing to the presence of a small number of key players. Leading players operating in the global neonatal jaundice meter market include:
- Dräger
- Delta Medical International
- Xuzhou Kejian Hi-tech
- Aegis Medicals
- Natus Medical
- Refine Medical Technology
- MandB
- Micro Lab
More Trending Reports by Transparency Market Research:
Biosimilars Market: Patent expiry of biologic drugs for the treatment of cancer are creating a scope for incremental opportunities. As such, oncology indication segment of the biosimilars market is estimated to reach a value of ~US$ 21.1 Bn by the end of 2027.
Cancer Cachexia Market: The global market for cancer cachexia market is currently in the budding stage. On the grounds of promising clinical pipeline and imminent regulatory approvals, this market is expected to witness exceptional rise over the coming years. The unmet need for the treatment of cancer cachexia in developing economies is also expected to drive the growth of this market substantially in the near future.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/